Avecho Biotechnology Ltd (AVE)

Currency in AUD
0.023
-0.001(-4.17%)
Closed·
Unusual trading volume
AVE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0220.025
52 wk Range
0.0040.027
Key Statistics
Bid/Ask
0.022 / 0.023
Prev. Close
0.024
Open
0.024
Day's Range
0.022-0.025
52 wk Range
0.004-0.027
Volume
27.43M
Average Volume (3m)
13.68M
1-Year Change
475%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AVE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Avecho Biotechnology Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Feb 27, 2026
EPS / Forecast
-- / --
Revenue / Forecast
677.69K / --
EPS Revisions
Last 90 days

AVE Income Statement

Compare AVE to Peers and Sector

Metrics to compare
AVE
Peers
Sector
Relationship
P/E Ratio
−20.8x−3.5x−0.4x
PEG Ratio
0.500.090.00
Price/Book
58.9x3.6x2.6x
Price / LTM Sales
74.3x3.4x3.0x
Upside (Analyst Target)
-83.7%53.6%
Fair Value Upside
Unlock23.1%7.6%Unlock

Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, France, and India. It operates through Production and Human Health segments. The company manufactures and sells TPM and Vital ET products for use in drug delivery and cosmetic formulations. Its human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. In addition, the company develops pharmaceutical products; oral, topical, and edible pharmaceutical cannabinoid products, including a cannabidiol TPM soft-gel capsule in Phase III clinical trial for the treatment of insomnia; and non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 and is based in Clayton, Australia.

Employees
15
Market
Australia

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
205.86K0.01%4.12K
Other Institutional Investors
562.72M14.69%11.25M
Public Companies & Retail Investors
3.27B85.30%65.35M
Total
3.83B100.00%76.61M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Paradyce Pty. Ltd.9.11%349,133,1886,983
Rosscope Pty Ltd2.35%89,973,9861,799

People Also Watch

0.418
EUR
-0.60%
0.032
EVG
-11.11%
0.041
IVG
-10.87%
0.31
CBE
-6.82%
0.004
HYD
+16.67%

FAQ

What Is the Avecho Bio (AVE) Stock Price Today?

The Avecho Bio stock price today is 0.023 AUD.

What Stock Exchange Does Avecho Bio Trade On?

Avecho Bio is listed and trades on the Sydney Stock Exchange.

What Is the Stock Symbol for Avecho Bio?

The stock symbol for Avecho Bio is "AVE."

What Is the Avecho Bio Market Cap?

As of today, Avecho Bio market cap is 88.100M AUD.

What Is Avecho Bio's Earnings Per Share (TTM)?

The Avecho Bio EPS (TTM) is -0.001.

From a Technical Analysis Perspective, Is AVE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Avecho Bio Stock Split?

Avecho Bio has split 1 times.

How Many Employees Does Avecho Bio Have?

Avecho Bio has 15 employees.

What is the current trading status of Avecho Bio (AVE)?

As of Jul 01, 2026, Avecho Bio (AVE) is trading at a price of 0.023 AUD, with a previous close of 0.024 AUD. The stock has fluctuated within a day range of 0.022 AUD to 0.025 AUD, while its 52-week range spans from 0.004 AUD to 0.027 AUD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.